These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18683992)

  • 1. Treatment of agitation in patients with schizophrenia.
    Marder SR
    J Clin Psychiatry; 2008 Jun; 69(6):e17. PubMed ID: 18683992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
    San L; Estrada G; Oudovenko N; Vieta E
    BMC Psychiatry; 2017 Apr; 17(1):126. PubMed ID: 28376877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia.
    Sacchetti E; Valsecchi P; Tamussi E; Paulli L; Morigi R; Vita A
    Psychiatry Res; 2018 Dec; 270():357-364. PubMed ID: 30293014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting.
    Correll CU; Yu X; Xiang Y; Kane JM; Masand P
    Ann Clin Psychiatry; 2017 May; 29(2):92-107. PubMed ID: 28463343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary issues in the field.
    Gorman JM
    CNS Spectr; 2005 Dec; 10(12):929. PubMed ID: 16344828
    [No Abstract]   [Full Text] [Related]  

  • 6. Old drug in new package promises to calm the agitated.
    Morrow T
    Manag Care; 2014 Apr; 23(4):50-1. PubMed ID: 24864536
    [No Abstract]   [Full Text] [Related]  

  • 7. Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.
    Brook S
    J Clin Psychiatry; 2003; 64 Suppl 19():13-8. PubMed ID: 14728085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled Loxapine for the Management of Acute Agitation in Bipolar Disorder and Schizophrenia: Expert Review and Commentary in an Era of Change.
    Pacciardi B; Calcedo A; Messer T
    Drugs R D; 2019 Mar; 19(1):15-25. PubMed ID: 30721526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological management of acutely agitated schizophrenic patients.
    San L; Arranz B; Escobar R
    Curr Pharm Des; 2005; 11(19):2471-7. PubMed ID: 16026300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.
    Breier A; Meehan K; Birkett M; David S; Ferchland I; Sutton V; Taylor CC; Palmer R; Dossenbach M; Kiesler G; Brook S; Wright P
    Arch Gen Psychiatry; 2002 May; 59(5):441-8. PubMed ID: 11982448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.
    Kinon BJ; Roychowdhury SM; Milton DR; Hill AL
    J Clin Psychiatry; 2001; 62 Suppl 2():17-21. PubMed ID: 11232746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and therapeutic aspects of agitation].
    San L
    Encephale; 2007 Jun; 33 Pt 3():S375-9. PubMed ID: 19101354
    [No Abstract]   [Full Text] [Related]  

  • 13. Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia.
    Gonzalez D; Bienroth M; Curtis V; Debenham M; Jones S; Pitsi D; George M
    Curr Med Res Opin; 2013 Mar; 29(3):241-50. PubMed ID: 23323879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment resistance in schizophrenia.
    Mirza S; Babu VS; Vithayathil E
    Br J Psychiatry; 1993 Sep; 163():409-10. PubMed ID: 8104654
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical perspectives on atypical antipsychotics for treatment of agitation.
    Caine ED
    J Clin Psychiatry; 2006; 67 Suppl 10():22-31. PubMed ID: 16965192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TDCS produces incremental gain when combined with working memory training in patients with schizophrenia: A proof of concept pilot study.
    Nienow TM; MacDonald AW; Lim KO
    Schizophr Res; 2016 Apr; 172(1-3):218-9. PubMed ID: 26852404
    [No Abstract]   [Full Text] [Related]  

  • 17. Cognitive-behavioral therapy for medication-resistant symptoms.
    Garety PA; Fowler D; Kuipers E
    Schizophr Bull; 2000; 26(1):73-86. PubMed ID: 10755670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A post hoc analysis of transitioning to oral treatment with olanzapine or haloperidol after 24-hour intramuscular treatment in acutely agitated adult patients with schizophrenia.
    Battaglia J; Houston JP; Ahl J; Meyers AL; Kaiser CJ
    Clin Ther; 2005 Oct; 27(10):1612-8. PubMed ID: 16330297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.
    Lesem MD; Zajecka JM; Swift RH; Reeves KR; Harrigan EP
    J Clin Psychiatry; 2001 Jan; 62(1):12-8. PubMed ID: 11235922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine.
    Walther S; Moggi F; Horn H; Moskvitin K; Abderhalden C; Maier N; Strik W; Müller TJ
    J Clin Psychopharmacol; 2014 Feb; 34(1):124-8. PubMed ID: 24346752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.